1. Home
  2. WSBF vs ACRS Comparison

WSBF vs ACRS Comparison

Compare WSBF & ACRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Waterstone Financial Inc. (MD)

WSBF

Waterstone Financial Inc. (MD)

HOLD

Current Price

$18.99

Market Cap

328.4M

Sector

Finance

ML Signal

HOLD

Logo Aclaris Therapeutics Inc.

ACRS

Aclaris Therapeutics Inc.

HOLD

Current Price

$4.32

Market Cap

311.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WSBF
ACRS
Founded
1921
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
328.4M
311.0M
IPO Year
2013
2015

Fundamental Metrics

Financial Performance
Metric
WSBF
ACRS
Price
$18.99
$4.32
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$10.20
AVG Volume (30 Days)
40.1K
1.2M
Earning Date
04-23-2026
05-07-2026
Dividend Yield
3.79%
N/A
EPS Growth
46.53
69.01
EPS
0.34
N/A
Revenue
N/A
$1,683,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$4.24
P/E Ratio
$55.79
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.08
$1.34
52 Week High
$19.08
$5.15

Technical Indicators

Market Signals
Indicator
WSBF
ACRS
Relative Strength Index (RSI) 59.89 45.83
Support Level $17.69 $4.15
Resistance Level N/A $4.62
Average True Range (ATR) 0.35 0.22
MACD 0.04 -0.04
Stochastic Oscillator 91.19 20.00

Price Performance

Historical Comparison
WSBF
ACRS

About WSBF Waterstone Financial Inc. (MD)

Waterstone Financial Inc is a holding company. Through its subsidiaries, it operates in two reportable segments: Community Banking and Mortgage Banking. The Community Banking segment provides consumer and business banking products and services to customers, which include various types of loans, deposits, and personal investment services. The Mortgage Banking segment involves residential mortgage loans for the primary purpose of sale in the secondary market. The majority of its revenue comes from the Community Banking segment.

About ACRS Aclaris Therapeutics Inc.

Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two reportable segments: therapeutics and contract research. The therapeutics segment is focused on identifying and developing inventive therapies to address unmet needs for immuno-inflammatory diseases, and the contract research segment is engaged in providing laboratory services. A majority of the company's revenue is derived from the therapeutics segment. The various drug candidates in its product pipeline are Zunsemetinib, which is an Oral MK2 Inhibitor; ATI-2138, an ITJ Inhibitor; Bosakitug, ATI-052, and Lepzacitinib.

Share on Social Networks: